The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders

Biomed Pharmacother. 2021 Jun:138:111519. doi: 10.1016/j.biopha.2021.111519. Epub 2021 Mar 20.

Abstract

Nuclear factor-κB (NF-κB) represents a group of inducible transcription factors (TFs) regulating the expression of a great variety of genes implicated in diverse processes, particularly modulation of immune system responses. This TF has functional interactions with non-coding RNAs, constructing a complicated network through which NF-κB, miRNAs, and lncRNAs coordinately regulate gene expression at different facets. This type of interaction is involved in the pathophysiology of several human disorders including both neoplastic disorders and non-neoplastic conditions. MALAT1 and NKILA are among lncRNAs whose interactions with NF-κB have been vastly assessed in different conditions including cancer and inflammatory conditions. In addition, miR-146a/b has functional interactions with this TF in different contexts. Although miRNAs have mutual interactions with NF-κB, the regulatory role of miRNAs on this TF has been more clarified. The aim of the current review is to explore the function of NF-κB-related miRNAs and lncRNAs in these two types of human disorders.

Keywords: LncRNA; MiRNA; NF-κB; Nuclear factor-κB.

Publication types

  • Review

MeSH terms

  • Humans
  • Inflammation Mediators / metabolism*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Protein Binding / physiology
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*

Substances

  • Inflammation Mediators
  • MicroRNAs
  • NF-kappa B
  • RNA, Long Noncoding